Einat Brill-Almon
Plus aucun poste en cours
Profil
Einat Brill-Almon worked as Director of Research & Development at Medgenics Medical (Israel) Ltd.
from 2001 to 2004.
She then worked at Protalix Biotherapeutics, Inc. from 2004 to 2022, where she held the position of Senior Vice President & Chief Development Officer from 2020 to 2022.
Prior to that, she was Senior Vice President of Product Development at Protalix Ltd.
Dr. Brill-Almon received her undergraduate degree from The Hebrew University of Jerusalem and her graduate and doctorate degrees from the Weizmann Institute of Science.
Anciens postes connus de Einat Brill-Almon
| Sociétés | Poste | Fin |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2022 |
Medgenics Medical (Israel) Ltd.
 Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Medgenics Medical Israel Ltd. develops protein delivery technology. The company is headquartered in Misgav, Israel. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
| Protalix Ltd. | Corporate Officer/Principal | - |
Formation de Einat Brill-Almon
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Medgenics Medical (Israel) Ltd.
Medgenics Medical (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Medgenics Medical Israel Ltd. develops protein delivery technology. The company is headquartered in Misgav, Israel. | Commercial Services |
| Protalix Ltd. |
